Shine Osteojoint: Dosing, Side Effect & Interaction

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Glucosamine HCl 500 mg, chondroitin sulfate Na 440 mg, methylsulfonylmethane (MSM) 400 mg

Indications/Uses

Adjuvant therapy for OA.

Click to view Shine Osteojoint detailed prescribing information

Dosage/Direction for Use

Adult Light to moderate OA 1 tab bd for at least 6 wk. Severe OA Initial therapy: 1 tab tds for at least 12 wk. Maintenance therapy: 1 tab bd for 3-4 mth.

Click to view Shine Osteojoint detailed prescribing information

Overdosage

View Shine Osteojoint overdosage for action to be taken in the event of an overdose.

Administration

Should be taken on an empty stomach.

Contraindications

Hypersensitivity to glucosamine, chondroitin or MSM. Allergy to seafood.

Click to view Shine Osteojoint detailed prescribing information

Special Precautions

Not a replacement for NSAIDs in cases of intense pain. Not to be given to patients allergic to seafood. May increase insulin resistance. Carefully monitor blood sugar levels in patients w/ type 2 diabetes, overwt & glucose tolerance problems. Severe hepatic or renal insufficiency. Not recommended during pregnancy & lactation. Avoid use during 1st 3 mth of pregnancy. Avoid use in childn.

Click to view Shine Osteojoint detailed prescribing information

Use In Pregnancy & Lactation

Click to view Shine Osteojoint detailed prescribing information

Adverse Reactions

Peripheral oedema, tachycardia; drowsiness, headache, insomnia; nausea, vomiting, diarrhoea, dyspepsia or epigastric pain, constipation, heartburn, anorexia; skin reactions eg, erythema, pruritus.

Drug Interactions

May reduce effectiveness w/ antidiabetic agents eg, acarbose, acetohexamide, chlorpropamide, glipizide, glyburide, metformin, miglitol, pioglitazone, repaglinide, rosiglitazone, glimepiride, tolbutamide, troglitazone. Reduced effectiveness of doxorubicin, etoposide, teniposide. Elevated INR serum values & potentiated anticoagulant effects of warfarin. Not to be used concomitantly w/ chitosan.

Click to view Shine Osteojoint detailed prescribing information

Storage

View Shine Osteojoint storage conditions for details to ensure optimal shelf-life.

Description

View Shine Osteojoint description for details of the chemical structure and excipients (inactive components).

Action

View Shine Osteojoint mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Other Drugs Acting on Musculo-Skeletal System

ATC Classification

M09AX - Other drugs for disorders of the musculo-skeletal system ; Used in the treatment of musculo-skeletal disorders.

Regulatory Classification

Presentation/Packing

Form

Shine Osteojoint FC tab

Packing/Price

60's

Shine Osteojoint

Manufacturer:

Y.S.P. Industries

Distributor:

Y.S.P. Industries